Official Title: Cognitive Control Amongst Older Adults with Depressive Symptom Mechanisms and Intervention
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GOLD-Cog
Brief Summary: The prevalence of depressive symptoms in older adults is on the rise affecting 13 to 37 of older adults globally These symptoms significantly impact health increasing the risk of dementia and cognitive decline and impairing daily functioning and quality of life Reduced cognitive control CC is a key factor contributing to depressive symptoms affecting 40 of adults with such symptoms Despite this over half of affected adults do not respond well to available treatments Computerized cognitive training CCT has shown efficacy in improving CC but its impact on daily functioning is limited The Cognitive Orientation to Occupational Performance CO-OP approach has demonstrated promise in improving daily functioning as measured by occupational performance OP We propose a novel intervention GOLD-Cog combining CCT and CO-OP to address CC and functional deficits in older adults with depressive symptoms
Detailed Description: The goal of this clinical trial is to investigate the relationship between mood and cognitive control in community-dwelling older adults 65 with sub-clinical depression and to assess feasibility efficacy and sustainability of a proposed combined cognitive intervention GOLD-Cog for this population group Cognitive control is the mental abilities that underlie our goal-directed behavior These mental abilities include the ability to shift our attention constantly monitoring and updating information provided by our environment and having the ability to inhibit unwanted reactions
The main questions of this study are
Question 1 What is the relationship between mood and cognitive control in daily life of older adults with depressive symptoms Question 2 Can this proposed combined cognitive intervention GOLD-Cog help improve daily functioning cognitive control mood quality of life and subjective cognition in older adults with depressive symptoms Question 3 Are the participants satisfied with this new proposed intervention
Participants will participate in a crossover randomized control trial in which they will participate in a 6-week experimental period and a 6-week waiting period During the experimental period they will take part in individual computerized cognitive training and functional-based goal-oriented group sessions